Current projects and partnering

London Genetics Limited is in discussion with a number of biopharmaceutical companies and contract research organisations about collaboration on drug development projects. We are open to further partnering opportunities and welcome your enquiries.

London Genetics is also developing a series of proof-of-concept (POC) studies with academic investigators via its POC fund, in order to investigate the potential of specific pharmacogenetic approaches in drug development. The projects are expected to illustrate the value the genetic data and resources within LGL’s seven academic founding partners can add to this process, and to show translational medicine in action.

The first awards from the London Genetics proof-of-concept fund have been made - read the press release here